157 related articles for article (PubMed ID: 31335741)
1. Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases: Study protocol for a randomized controlled trial.
Chen X; Yan D; Fang J; Liu W; Nie H; Lv N; Fang N; Gong J; Yu J; Jiang Y; Liu Z; Gan H; Fu Y; Yang D; Xiong Y; Liu D; Chen M; Wang Y; Wang Y; Sun X; Zhou X; Zhu W
Medicine (Baltimore); 2019 Jul; 98(29):e16561. PubMed ID: 31335741
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Zhou X; Yan DM; Zhu WF; Liu WJ; Nie HY; Xu S; Jiang YP; Zhang KH; Fu Y; Wan YY; Yu XY; Li H; Sun X; Chen XF
Trials; 2019 Jun; 20(1):343. PubMed ID: 31182140
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial.
Chen X; Nie H; Liu W; Zhou X; Nie J; Xie B; Chen D; Jiang Y; Zhang K; Fu Y; Yang D; Xiong Y; Zhao Z; Sun X; Zhu W
Evid Based Complement Alternat Med; 2018; 2018():1980491. PubMed ID: 30622590
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
[TBL] [Abstract][Full Text] [Related]
8. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Feng LY; Yao XX; Jiang SL
World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
[TBL] [Abstract][Full Text] [Related]
9. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
10. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
11. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
Olafsson S; Hatlebakk JG; Berstad A
Scand J Gastroenterol; 2002 Dec; 37(12):1386-94. PubMed ID: 12523587
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
Huang SC; Sheu BS; Lee SC; Yang HB; Yang YJ
J Formos Med Assoc; 2010 Jan; 109(1):75-81. PubMed ID: 20123589
[TBL] [Abstract][Full Text] [Related]
16. [A multicenter study of Chinese patent medicine wenweishu/yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer].
; Hu FL
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):75-8. PubMed ID: 20356485
[TBL] [Abstract][Full Text] [Related]
17. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford AC; Delaney BC; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
[TBL] [Abstract][Full Text] [Related]
18. [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
Choi BK; Yang SY; Park ET; Jang YS; Lee YJ; Lee SH; Seol SY; Chung JM
Korean J Gastroenterol; 2003 Aug; 42(2):102-7. PubMed ID: 14532713
[TBL] [Abstract][Full Text] [Related]
19. Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study.
Zhu H; Pan X; Zhang L; Sun H; Fan H; Pan Z; Huang C; Shi Z; Ding J; Wang Q; Du Y; Lyu N; Li Z
Chin Med J (Engl); 2022 Dec; 135(24):2941-2949. PubMed ID: 36580650
[TBL] [Abstract][Full Text] [Related]
20. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
